3rd Quarter - Report

VENABLE LLP for ENDO PHARMACEUTICALS INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues relating to incentives for life sciences research. H.R. 160- Protect Medical Innovation Act of 2015

LobbyistCovered position, as disclosed
WILLIAM R NORDWIND —
ROBERT L SMITH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 160 (114th)

Copyright/Patent/Trademark CPT

Oversight of implementation of the America Invents Act.

LobbyistCovered position, as disclosed
WILLIAM R NORDWIND —
ROBERT L SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues relating to prescription drug abuse; Issues relating to incentives for tamper-resistant formulations; H.R. 471 Ensuring Patient Access and Effective Drug Enforcement Act of 2015; Issues relating to the labeling of generic drugs; Issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H.R. 106. Issues relating to bioequivalence and related administrative procedures; Issues relating to incentives for tamper-resistant formulation, Issues relating to Medicare Part D rebates; Issues relating to products containing high doses of acetaminophen.

LobbyistCovered position, as disclosed
WILLIAM R NORDWIND —
ROBERT L SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 471 (114th), H.R. 106 (114th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.